Enrico Montefusco

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols.

Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols.

Journal: Acta oncologica (Stockholm, Sweden)

Published: August 31, 2021

Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group".

Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group".

Journal: European journal of haematology

Published: March 18, 2020

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.

Journal: Blood advances

Published: August 20, 2019

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.

Journal: Annals of hematology

Published: April 16, 2019

Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?

Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?

Journal: Leukemia research

Published: August 25, 2018

High platelet count at diagnosis is a protective factor for thrombosis in patients with essential thrombocythemia.

High platelet count at diagnosis is a protective factor for thrombosis in patients with essential thrombocythemia.

Journal: Thrombosis research

Published: February 12, 2017

Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome.

Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome.

Journal: British journal of haematology

Published: February 08, 2017

Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia.

Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia.

Journal: Cancer medicine

Published: September 15, 2016

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.

Journal: Oncotarget

Published: June 07, 2016

Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.

Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.

Journal: American journal of hematology

Published: August 28, 2015

Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.

Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.

Journal: European journal of haematology

Published: August 10, 2015

Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis.

Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis.

Journal: Leukemia research

Published: November 03, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026